News Daily News Black and Hispanic Patients Not Accessing High-Volume TEER Centers Michael O'Riordan July 19, 2022
News Daily News Shock in Peripartum Cardiomyopathy Especially Risky in Black, Hispanic Patients Caitlin E. Cox July 13, 2022
News Daily News Postop AF Portends Higher Risk of HF Hospitalization in the Next Few Years Caitlin E. Cox June 30, 2022
News Features As US Abortion Protections Are Lost, Cardiologists Brace for Impact Todd Neale June 24, 2022
News Conference News ESC Heart Failure 2022 Sweet Spot for Omecamtiv Mecarbil in HFrEF May Lie in Low SBP Patients Shelley Wood May 23, 2022
News Daily News ESC Heart Failure 2022 SERENADE: No Benefit, Possible Harm With Macitentan in HFpEF and PAH Shelley Wood May 22, 2022
News Conference News HRS 2022 Gains in HF Drug Therapy Raise Questions About ICD Benefit in Modern Era Todd Neale May 02, 2022
News Conference News ACC 2022 SODIUM-HF: No Impact of Tighter Dietary Salt Restriction on Death or Hospitalization L.A. McKeown April 02, 2022
News Conference News ACC 2022 New HF Guidelines Stress Four-Drug Approach, ‘HFmrEF,’ Amyloidosis Options, and More Shelley Wood April 01, 2022
News Conference News ACC 2022 What’s Going to Be Hot at ACC 2022, In Person or Virtual Shelley Wood March 28, 2022
News Daily News Heart Transplant Recipients Fare Poorer When Stroke Is Cause of Death for Younger Donors Yael L. Maxwell March 17, 2022
News Conference News THT 2022 LAVA ECMO: Early Data Point to Hemodynamic Benefits, Safety Caitlin E. Cox February 02, 2022
Presentation THT 2022 CON - Patients with Group 2 Pulmonary Hypertension are not candidates for interatrial shunts! Presenter: Liviu Klein February 01, 2022
Presentation THT 2022 PRO - Patients with Group 2 Pulmonary Hypertension are not candidates for interatrial shunts! Presenter: Roham Zamanian February 01, 2022
News Daily News Cardiac Abnormalities Seen After COVID-19, but Recovery Is Quick Michael O'Riordan January 20, 2022
News Daily News Using Donor Hearts After Circulatory Death Is Feasible for Transplantation Michael O'Riordan January 12, 2022